Pfizer Resubmits Application for COVID-19 Vaccine for Children Under 5

The FDA reportedlyaccepted Pfizer’s applicationto look at the data Wednesday.

Pfizer said last week that trials showed its three-dose vaccineproduced a strong immune responsein children under 5.

Moderna asked for approvalat the end of April.

Pfizer’s is three 3-microgram doses – one-tenth of the dose for adults.

The FDA didn’t immediately respond to a request for comment.

The vaccine would have to be approved by the committee before the full FDA, followed by CDC approval.